Table 6: Results at Week 52 in a Trial of MOUNJARO versus Insulin Glargine in Adult Patients with Type 2 Diabetes Mellitus Added to Metformin and/or Sulfonylurea and/or SGLT2 Inhibitor MOUNJARO Use In Combination With Basal Insulin With Or Without Metformin In Adult Patients With Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
Short-term side effects were not observed in this small population, and they did not evaluate if it actually worked for a specific condition or if it was safe for long-term use. Jamie Richardson, BVetMed, head of veterinary medicine at Small Door Veterinary, shares the same concerns
No Real Medical Exam Many predatory sites will ship you a prescription medication after nothing more than a quick online questionnaireheight, weight, a credit card, done
How do semaglutide weight loss injections actually work